-
01
-
Abou-Donia MB, Ibrahim SM, Corcoran JJ, et al. Neurotoxicity of glycinamide, an acrylamide metabolite. J Toxicol Environ Health 1993;39:447-64.
PMID 8345532
-
02
-
Ando K, Hashimoto K. Accumulation of (14-C)-acrylamide in mouse nerve tissue. Proc Osaka Perfectural Inst Pub Health 1972;10:7-12.
-
03
-
Barber DS, Hunt J, Lo Pachin RM, Ehrich M. Determination of acrylamide and gylcidamide in rat plasma by reversed-phase high performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001;758:289-93.
PMID 11486839
-
04
-
Berger AR, Schaumburg HH. Effects of occupational and environmental agents on the nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. Butterworth Heinemann, 1996.
-
05
-
Berger AR, Schaumburg HH, Schroeder C, Apfel S, Reynolds R. Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: prospective study of pyridoxine neurotoxicity. Neurology 1992;42:1367-70.
PMID 1620347
-
06
-
Cavanaugh JB. The significance of the "dying-back" process in experimental and human neurological disease. Int Rev Exp Pathol 1964;3:219-67.
-
07
-
Dixit R, Mukhtar H, Seth PK, Murti CR. Conjugation of acrylamide with glutathione catalyzed by glutathione-S-transferase in rat liver and brain. Biochem Pharmacol 1981;30:1739-40.
PMID 7271861
-
08
-
Duarte-Salles T, von Stedingk H, Granum B, et al. Dietary acrylamide intake during pregnancy and fetal growth-results from the Norwegian mother and child cohort study (MoBa). Environ Health Perspect 2013;121:374-9.
PMID 23204292
-
09
-
Feldman RG. Acrylamide. In: Occupational and environmental toxicology. Philadelphia: Lippincott-Raven Publishers, 1999;337-58.
-
10
-
Fujita A, Shibata J, Kato H, et al. Clinical observations of three cases of acrylamide poisoning. Nippon Ijo Shimpo 1960;1869:37-40.
-
11
-
Fullerton PM. Electrophysiologic and histologic observations on the peripheral nerves in acrylamide poisoning in man. J Neurol Neurosurg Psychiatry 1969;32:186-92.
PMID 4307538
-
12
-
Gold BG, Griffin JW, Price DL. Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration. J Neurosci 1985;5:1755-68.
PMID 2410575
-
13
-
Kjuus H, Goffeng LO, Heier MS, et al. Effects on the peripheral nervous system of tunnel workers exposed to acrylamide and N-methylolacrylamide. Scand J Work Environ Health 2004;30(1):21-9.
PMID 15018025
-
14
-
Ko MH, Chen WP, Hsieh ST. Neuropathology of skin denervation in acrylamide-induced neuropathy. Neurobiol Dis 2002;11:155-65.
PMID 12460555
-
15
-
Kuperman AS. Effects of acrylamide on the central nervous system of the cat. J Pharmacol Exp Ther 1958;123:180-92.
PMID 13564393
-
16
-
Lehning EJ, Balaban CD, Ross JF, LoPachi RM. Acrylamide neuropathy. II. Spatiotemporal characteristics of nerve cell damage in brainstem and spinal cord. Neurotoxicology 2003;24:109-23.
PMID 12564387
-
17
-
LoPachin RM, Balaban CD, Ross JF. Acrylamide axonopathy revisited. Toxicol Appl Pharmacol 2003;188(3):135-53.
PMID 12729714
-
18
-
LoPachin RM, Gavin T. Toxic neuropathies: mechanistic insights based on a chemical perspective. Neurosci Lett 2015;596:78-83.
PMID 25218479
-
19
-
Miller MS, Spencer PS. Single doses of acrylamide reduce retrograde transport velocity. J Neurochem 1984;43:1401-8.
PMID 6208333
-
20
-
Park RM. Preliminary risk assessment for acrylamide and peripheral neuropathy. Neurotoxicology 2021;85:10-7.
PMID 33892018
-
21
-
Schaumburg HH, Arezzo JC, Spencer PS. Delayed onset of axonal neuropathy in primates after prolonged low-level administration of a neurotoxin. Ann Neurol 1989;26:576-9.
PMID 2817831
-
22
-
Schaumburg HH, Wisniewski HM, Spencer PS. Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol 1974;33:260-84.
PMID 4362700
-
23
-
Spencer PS, Schaumburg HH. Central-peripheral distal axonopathy-the pathogenesis of dying back polyneuropathies. In: Zimmerman H, editor. Progress in neuropathology. Vol 3. New York: Grune and Stratton, 1976:253-95.
-
24
-
Spencer PS, Schaumburg HH. Ultrastructural studies of the dying back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol 1977;36:276-99.
PMID 190357
-
25
-
Stone JD, Peterson AP, Eyer J, Sickles DW. Neurofilaments are non-essential elements of toxicant-induced reductions in fast axonal transport: pulse labeling in CNS neurons. Neurotoxicology 2000;21:447-57.
PMID 11022855
-
26
-
Tandrup T. Chromatolysis of A-cells of dorsal root ganglia is a primary structural event in acute acrylamide intoxication. J Neurocytol 2002;31:73-8.
PMID 12652089
-
27
-
Yu S, Son F, Yu J, et al. Acrylamide alters cytoskeletal protein level in rat sciatic nerves. Neurochem Res 2006;31(10):1197-204.
PMID 17043767
-
28
-
Zhu YJ, Zeng T, Zhu YB, et al. Effects of acrylamide on the nervous tissue antioxidant system and sciatic nerve electrophysiology in the rat. Neurochem Res 2008;33:2310-7.
PMID 18470611